반응식
[C:1]([O:10]C1C=CC=CC=1)(=O)[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[CH2:17]([C:19]1[CH:25]=[CH:24][CH:23]=[CH:22][C:20]=1[NH2:21])[CH3:18]>>[CH2:17]([C:19]1[CH:25]=[CH:24][CH:23]=[CH:22][C:20]=1[NH:21][C:1](=[O:10])[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4])[CH3:18]참가 물질
3
실험 절차
The 2′-ethyl-salicylanilide was prepared by condensing phenyl salicylate with 2-ethylaniline then purified as described in Example 2a. The ligand mixture was then prepared from 2′-ethyl-salicylanilide and 1,1′-bi-2-naphthol using the procedure described in Example 2a. 31P NMR (121.77 MHz): several peaks between 117.1-118.8 ppm.
후처리
- customthen purified
- customThe ligand mixture was then prepared from 2′-ethyl-salicylanilide and 1,1′-bi-2-naphthol using the procedure
출처 및 근거
- ORD 기록
- ord-4bbf13c0bf514f11b9c4464537d267e6
- 출처 데이터셋
- uspto-grants-2003_12
- 특허 번호
- US06664427B1
연결된 노트
불러오는 중…